Bipolar Disorder Clinical Trials in San Antonio

Showing 41-60 of 87 trials

Effectiveness of Two Self Assessment Tools: KIOS-Bipolar or eMoods

NCT02418910

The goal of this project is to complete the development of a patient-centered software system and mobile app to assist in managing bipolar disorder. In Phase I, the investigators developed a novel computational tool known as KIOS. Based on concepts from nonlinear systems (chaos) theory, KIOS tracks multiple interacting symptoms to determine the precise state of a BD patient. Once the patient's state is identified and the trajectory of the patient is established, KIOS produces advice specific to the patient's condition to help manage the course of the disease. To demonstrate the usability of the software, KIOS was converted to an online tool with mobile access. Twenty bipolar patients evaluated KIOS in a twelve week field trial. No technical problems with the software were observed and results showed that patients had significantly more reductions in symptom severity than increases. The development of this innovative tool to help patients self- manage BD has the potential to have a profound impact on public health and achieve significant commercial success.

Bipolar Disorder

The University of Texas Health Science Center at San Antonio50 participantsStarted Oct 2015

San Antonio, Texas, United States

COMPLETEDPhase 1< 1 mile

Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders

NCT03292848

A study to assess pharmacokinetics, safety and tolerability of brexpiprazole in children ages 6 to \<13 years with CNS disorders.

ADHDAutismBipolar I Disorder+2 more

Otsuka Pharmaceutical Development & Commercialization, Inc.24 participantsStarted Oct 2017

Little Rock, Arkansas, United States • Rogers, Arkansas, United States • Long Beach, California, United States +6 more locations

Effectiveness of Two Self Assessment Tools: KIOS-Bipolar or eMoods

Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders

Bipolar Disorder Trials in Other Cities

Comparative Effectiveness Study for Bipolar Disorder

12- Week Open Label Treatment of Refractory Bipolar Depression

Bipolar Disorder Study for Men and Women

Bipolar Study in Adults at Least 18 Years of Age

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder

Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder

Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Pediatric Bipolar Depression

CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296

Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression

Depression And Bipolar Disorder

Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384)

Safety and Efficacy of Cariprazine for Bipolar I Disorder

A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder

Study in Adolescents With Schizophrenia or Bipolar Disorder

Other Conditions in San Antonio